Selected Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2019



	First		Second		Third		Fourth
	Quarter		Quarter		Quarter		Quarter
REVENUE:
2019	$	67,505	$	71,139	$	67,881	$	69,697
2018		61,948		68,496		64,598		67,799
2017		45,059		47,818		43,999		52,826	^*

GROSS MARGIN:
2019	$	44,273	$	46,966	$	45,222	$	46,552
2018		39,228		45,851		42,714		45,191
2017		29,512		32,905		29,862		36,363	^*

NET (LOSS) INCOME:
2019	$	(297)	$	2,832	$	(134)	$	(681)
2018		(3,855)		226		1,565		(776)
2017		2,223		3,163		1,325		(3,007)	^*

(LOSS) INCOME PER COMMON SHARE—DILUTED:
2019	$	(0.01)	$	0.07	$	0.00	$	(0.02)
2018		(0.11)		0.01		0.04		(0.02)
2017		0.06		0.09		0.04		(0.09)	^*

_____________________

^*In December 2017 we completed our acquisition of JOTEC, which is operated as a wholly-owned subsidiary of CryoLife.